Sector Update: Tech Stocks Fall Premarket Thursday

MT newswire2026/10/08 13:16

09:16 AM EDT, 10/08/2026 (MT Newswires) -- Technology stocks were falling premarket Thursday, with the State Street Technology Select Sector SPDR Fund (XLK) down 0.7% and the iShares Semiconductor ETF (SOXX) 1.7% lower. Taiwan Semiconductor Manufacturing (TSM) reported revenue of 511.86 billion New Taiwan dollars ($16.03 billion) in September, up 55% from a year earlier. TSMC shares were down more than 1% pre-bell. SK Hynix's (SKHY) flash-memory spin-off Solidigm has chosen Goldman Sachs (GS) and Morgan Stanley (MS) to assemble its US initial public offering next year, Bloomberg reported, citing people familiar with the matter. Shares of SK Hynix were down more than 1% premarket. Accenture (ACN) and Dell (DELL) said they are creating a new business group to help organizations scale artificial intelligence and modernize infrastructure. Dell Technologies stock was down more than 1% pre-bell.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks

AiCoin•2026/10/13 03:03

BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%

Odaily星球日报•2026/10/13 03:01

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56